Trial

LG Offers Three-Month Free Trial for Apple TV+ To Smart TV and Lifestyle Screen Owners

LG Offers Three-Month Free Trial for Apple TV+ To Smart TV and Lifestyle Screen Owners

LG Offers Three-Month Free Trial for Apple TV+ To Smart TV and Lifestyle Screen Owners

AETOSWire February 6, 2024

LG Smart TV Users Gain Free Access to Wide Selection of Apple Originals, Hit Shows and Feature...

BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

AETOSWire August 22, 2023

SAMMAMISH, Wash. — BaroPace Inc., a medical device company focused on the development of PressurePace™, a real-time...

BaroPace Receives Approval for First-in-Human Clinical Trial

BaroPace Receives Approval for First-in-Human Clinical Trial

AETOSWire July 25, 2023

SAMMAMISH, Wash. — BaroPace, Inc., a medical technology company dedicated to using blood pressure to regulate pacemakers...

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies

AETOSWire February 6, 2023

CRANBURY, N.J. — Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today...

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

AETOSWire January 25, 2023

WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety...

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer $Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer$

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

AETOSWire September 13, 2022

PARIS — Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the investigational combination...

World-First Trial of 5G HAPS Technology Takes Place in Saudi Arabia In the Red Sea Project

World-First Trial of 5G HAPS Technology Takes Place in Saudi Arabia In the Red Sea Project

World-First Trial of 5G HAPS Technology Takes Place in Saudi Arabia In the Red Sea Project

AETOSWire March 4, 2022

RIYADH, Saudi Arabia: UK company Stratospheric Platforms Limited (SPL), a partner of German telecommunications company Deutsche Telekom...

TXAI, the UAE’s First Autonomous Taxi Operation Completes Successful Phase 1 Trial

TXAI, the UAE’s First Autonomous Taxi Operation Completes Successful Phase 1 Trial

TXAI, the UAE’s First Autonomous Taxi Operation Completes Successful Phase 1 Trial

AETOSWire February 11, 2022

ABU DHABI, United Arab Emirates–(BUSINESS WIRE/AETOSWire)– Bayanat, a G42 company, and the leader in geospatial intelligence, data...